| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |